Suppr超能文献

新城疫病毒对淋巴瘤细胞的优先细胞毒性作用。

Preferential cytotoxic effect of Newcastle disease virus on lymphoma cells.

作者信息

Bar-Eli N, Giloh H, Schlesinger M, Zakay-Rones Z

机构信息

Department of Virology, Hebrew University Hadassah Medical School, Jerusalem, Israel.

出版信息

J Cancer Res Clin Oncol. 1996;122(7):409-15. doi: 10.1007/BF01212880.

Abstract

Susceptibility of lymphoma cells (Daudi, HD-Mar) to Newcastle disease virus toxicity was found to be higher than that of lymphoblastoid cells (Milstein) and of resting peripheral blood lymphocyte (PBL). Phytohemagglutinin- and/or pokeweed-mitogen-activated PBL however, exhibited, elevated sensitivity, similar to that of lymphoma cells. The level of cytotoxicity was monitored by cell viability, inhibition of DNA synthesis and release of 51Cr. When Daudi cells were mixed with PBL they were significantly more sensitive to the killing effect of the virus (70% mortality compared to 30% 30 h after infection, P < 0.05). The degree of sensitivity to viral cytotoxicity was unrelated to the efficacy of adsorption, which was similar for all cell lines as shown by immunofluorescent staining and flow cytometry. Also an influenza strain A/PR/8/34 (H1N1) adsorbed but did not affect the viability of any of the cells tested. Our results demonstrate that New-castle disease virus caused preferential damage to lymphoma cells as compared to non-cancerous normal cells.

摘要

研究发现,淋巴瘤细胞(Daudi、HD-Mar)对新城疫病毒毒性的敏感性高于淋巴母细胞(米尔斯坦细胞系)和静息外周血淋巴细胞(PBL)。然而,经植物血凝素和/或商陆有丝分裂原激活的PBL表现出与淋巴瘤细胞相似的更高敏感性。通过细胞活力、DNA合成抑制和51Cr释放来监测细胞毒性水平。当Daudi细胞与PBL混合时,它们对病毒的杀伤作用明显更敏感(感染30小时后死亡率为70%,而PBL为30%,P<0.05)。对病毒细胞毒性的敏感程度与吸附效率无关,免疫荧光染色和流式细胞术显示所有细胞系的吸附情况相似。同样,甲型流感病毒株A/PR/8/34(H1N1)能吸附但不影响任何受试细胞的活力。我们的结果表明,与非癌正常细胞相比,新城疫病毒对淋巴瘤细胞造成了优先损伤。

相似文献

3
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
4
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.

引用本文的文献

4
Recent advances of oncolytic virus in cancer therapy.溶瘤病毒在癌症治疗中的最新进展。
Hum Vaccin Immunother. 2020 Oct 2;16(10):2389-2402. doi: 10.1080/21645515.2020.1723363. Epub 2020 Feb 20.
5
Fusogenic Viruses in Oncolytic Immunotherapy.溶瘤免疫疗法中的融合病毒
Cancers (Basel). 2018 Jun 26;10(7):216. doi: 10.3390/cancers10070216.

本文引用的文献

2
Determination of cell viability.细胞活力的测定。
Proc Soc Exp Biol Med. 1958 May;98(1):188-92. doi: 10.3181/00379727-98-23985.
10
Participation of lymphocytes in viral infections.淋巴细胞在病毒感染中的作用。
Adv Immunol. 1973;16:123-84. doi: 10.1016/s0065-2776(08)60297-7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验